Home » News » World » Molecular Partners Completes Manufacturing Runs in Bid for Covid-19 Drug
1-MIN READ

Molecular Partners Completes Manufacturing Runs in Bid for Covid-19 Drug

Reuters

Last Updated: September 14, 2020, 11:34 IST

Zurich

Representational Image: Reuters

Representational Image: Reuters

Switzerland's Molecular Partners said on Monday that it had completed initial manufacturing runs for its candidate MP0420 that it aims to test in humans starting in November.

Switzerland’s Molecular Partners, which is hoping to produce an antiviral drug against COVID-19, said on Monday that it had completed initial manufacturing runs for its candidate MP0420 that it aims to test in humans starting in November.

“It is essential to demonstrate the ability to manufacture and deploy these medicines,” said Chief Executive Patrick Amstutz.

first published:September 14, 2020, 11:34 IST
last updated:September 14, 2020, 11:34 IST